Prof. Dr. Iris Löw-Friedrich - Net Worth and Insider Trading

Prof. Dr. Iris Löw-Friedrich Net Worth

The estimated net worth of Prof. Dr. Iris Löw-Friedrich is at least $0 dollars as of 2025-07-25. Prof. Dr. Iris Löw-Friedrich is the Supervisory Board of Evotec SE and owns about 0 shares of Evotec SE (XTER:EVT) stock worth over $0. Details can be seen in Prof. Dr. Iris Löw-Friedrich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Prof. Dr. Iris Löw-Friedrich has not made any transactions after 2024-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Prof. Dr. Iris Löw-Friedrich

Prof. Dr. Iris Löw-Friedrich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Prof. Dr. Iris Löw-Friedrich owns 1 companies in total, including Evotec SE (XTER:EVT) .

Click here to see the complete history of Prof. Dr. Iris Löw-Friedrich’s form 4 insider trades.

Insider Ownership Summary of Prof. Dr. Iris Löw-Friedrich

Ticker	Company	Transaction Date	Type of Owner
XTER:EVT	Evotec SE	2024-08-28	Supervisory Board

Prof. Dr. Iris Löw-Friedrich Latest Holdings Summary

Prof. Dr. Iris Löw-Friedrich currently owns a total of 1 stock. Prof. Dr. Iris Löw-Friedrich owns 0 shares of Evotec SE (XTER:EVT) as of August 28, 2024, with a value of $0.

Latest Holdings of Prof. Dr. Iris Löw-Friedrich

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XTER:EVT	Evotec SE	2024-08-28	0	6.36	0

Holding Weightings of Prof. Dr. Iris Löw-Friedrich

Prof. Dr. Iris Löw-Friedrich Form 4 Trading Tracker

According to the SEC Form 4 filings, Prof. Dr. Iris Löw-Friedrich has made a total of 1 transactions in Evotec SE (XTER:EVT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Evotec SE is the acquisition of 15,000 shares on August 28, 2024, which cost Prof. Dr. Iris Löw-Friedrich around $100,050.

Insider Trading History of Prof. Dr. Iris Löw-Friedrich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Prof. Dr. Iris Löw-Friedrich Trading Performance

GuruFocus tracks the stock performance after each of Prof. Dr. Iris Löw-Friedrich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Prof. Dr. Iris Löw-Friedrich is 41.52%. GuruFocus also compares Prof. Dr. Iris Löw-Friedrich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Prof. Dr. Iris Löw-Friedrich within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Prof. Dr. Iris Löw-Friedrich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Prof. Dr. Iris Löw-Friedrich

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-1.72
Relative Return to S&P 500(%)	-4.33

Prof. Dr. Iris Löw-Friedrich Ownership Network

Ownership Network List of Prof. Dr. Iris Löw-Friedrich

No Data

Ownership Network Relation of Prof. Dr. Iris Löw-Friedrich

Prof. Dr. Iris Löw-Friedrich Owned Company Details

What does Evotec SE do?

Who are the key executives at Evotec SE?

Prof. Dr. Iris Löw-Friedrich is the Supervisory Board of Evotec SE. Other key executives at Evotec SE include Board of Directors Dr. Christian Wojczewski , Board of Directors Aurélie Dalbiez , and Board of Directors Dr. Craig Johnstone .

Evotec SE (XTER:EVT) Insider Trades Summary

Over the past 18 months, Prof. Dr. Iris Löw-Friedrich made 1 insider transaction in Evotec SE (XTER:EVT) with a net purchase of 15,000. Other recent insider transactions involving Evotec SE (XTER:EVT) include a net purchase of 50,000 shares made by Dr. Christian Wojczewski , a net sale of 19,726 shares made by Dr. Cord Dohrmann , and a net purchase of 3,517 shares made by Aurélie Dalbiez .

In summary, during the past 3 months, insiders sold 0 shares of Evotec SE (XTER:EVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,726 shares of Evotec SE (XTER:EVT) were sold and 71,517 shares were bought by its insiders, resulting in a net purchase of 51,791 shares.

Evotec SE (XTER:EVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evotec SE Insider Transactions

No Available Data

Prof. Dr. Iris Löw-Friedrich Mailing Address

Above is the net worth, insider trading, and ownership report for Prof. Dr. Iris Löw-Friedrich. Currently GuruFocus does not have mailing address information for Prof. Dr. Iris Löw-Friedrich.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.